Preclinical carotid atherosclerosis is independently associated with cardiovascular events and mortality in type 1 diabetes.
12 affiliations
- 1Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. [email protected].
- 2Fundació Clínic per la recerca biomèdica, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. [email protected].
- 3Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain.
- 4Fundació Clínic per la recerca biomèdica, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
- 5Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- 6Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
- 7Endocrinology and Nutrition Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain.
- 8Endocrinology and Nutrition, Centro Médico Milenium, Gran Vía Santiago Ramón y Cajal 9, 50005, Zaragoza, Spain.
- 9Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. [email protected].
- 10Fundació Clínic per la recerca biomèdica, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. [email protected].
- 11Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [email protected].
- 12Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. [email protected].
Abstract
Background
To evaluate whether carotid atherosclerosis predicts future cardiovascular events (CVE) and mortality in adults with type 1 diabetes (T1D) in primary prevention.Methods
Cohort study in adults with T1D participating in a cardiovascular risk assessment program that included carotid ultrasound. Eligibility criteria included age ≥ 40 years, diabetic kidney disease regardless of age or diabetes duration, or type 1 diabetes duration ≥ 10 years in the presence of at least one additional cardiovascular risk factor.The primary endpoint was the first CVE. A secondary endpoint was a composite of CVE plus all-cause mortality. Carotid plaque burden and outcomes were analyzed using Kaplan-Meier curves and Cox regression models.Results
701 individuals were followed for a mean of 5.85 years (mean age 48.5 years; T1D duration 27 years; 51.9% males). Carotid plaques were identified in 40.4%. During follow-up, 45 CVE occurred (18 coronary artery disease, 14 peripheral artery disease, 6 stroke, 3 heart failure, 4 deaths) along with 5 non-cardiovascular deaths. Event-free survival declined progressively with increasing plaque burden (log-rank p < 0.001). In unadjusted analyses, the presence of any plaque was associated with increased risk of CVE (HR 3.14, 95%C I 1.69-5.84) and of the composite endpoint (HR 3.07, 95% CI 1.71-5.51). After multivariable adjustment for demographic, metabolic, and microvascular factors, a high plaque burden (≥ 3 plaques) remained associated with CVE (HR 3.38, 95% CI 1.37-8.38) and with the composite endpoint (HR 2.64, 95% CI 1.13-6.21).Conclusions
Preclinical carotid atherosclerosis in adults with T1D was independently associated with an increased risk of cardiovascular events and mortality. These findings support the potential role of carotid ultrasound as a complementary tool for cardiovascular risk assessment in individuals with T1D.
Related
- Integrated Clinical, Biological, and Echocardiographic Factors Independently Associated With In-Hospital Mortality in Infective Endocarditis: A Single-Centre Cohort Study From Morocco
- CO058 | ELEVATED PLASMA LEVELS OF OMEGA-3 STEARIDONIC ACID ARE ASSOCIATED WITH DECREASED FACTOR VIII COAGULANT ACTIVITY INDEPENDENTLY OF FACTOR VIII ANTIGEN AND VON WILLEBRAND FACTOR LEVELS: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT STUDY
- Factors Associated With Uncontrolled Blood Pressure and Its Association With Cardiovascular and All-Cause Mortality Among Adults Receiving Antihypertensive Therapy: A Retrospective Cohort Study Using NHANES 2013-2018 Linked Mortality Data
- Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality.
- Temporal trends and disparities in mesenteric ischemia–associated cardiovascular mortality among U.S. adults aged ≥45 years, 1999–2023
BibTeX
@article{vinals2026preclinical,
title = {{Preclinical carotid atherosclerosis is independently associated with cardiovascular events and mortality in type 1 diabetes.}},
author = {Clara Viñals and Ignacio Conget and Camila Milad and Montse Granados and Jesús Blanco and Maria Claro and Verónica Perea and Tonet Serés-Noriega and Irene Vinagre and Marga Giménez and Antonio J Amor},
journal = {Cardiovascular diabetology},
year = {2026},
month = jul,
doi = {10.1186/s12933-026-03300-2},
url = {https://europepmc.org/article/MED/42897549},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Preclinical carotid atherosclerosis is independently associated with cardiovascular events and mortality in type 1 diabetes.
AU - Clara Viñals
AU - Ignacio Conget
AU - Camila Milad
AU - Montse Granados
AU - Jesús Blanco
AU - Maria Claro
AU - Verónica Perea
AU - Tonet Serés-Noriega
AU - Irene Vinagre
AU - Marga Giménez
AU - Antonio J Amor
PY - 2026
DA - 2026/07/01
JO - Cardiovascular diabetology
DO - 10.1186/s12933-026-03300-2
UR - https://europepmc.org/article/MED/42897549
AB - Background To evaluate whether carotid atherosclerosis predicts future cardiovascular events (CVE) and mortality in adults with type 1 diabetes (T1D) in primary prevention.Methods Cohort study in adults with T1D participating in a cardiovascular risk assessment program that included carotid ultrasound. Eligibility criteria included age ≥ 40 years, diabetic kidney disease regardless of age or diabetes duration, or type 1 diabetes duration ≥ 10 years in the presence of at least one additional cardiovascular risk factor.The primary endpoint was the first CVE. A secondary endpoint was a composite of CVE plus all-cause mortality. Carotid plaque burden and outcomes were analyzed using Kaplan-Meier curves and Cox regression models.Results 701 individuals were followed for a mean of 5.85 years (mean age 48.5 years; T1D duration 27 years; 51.9% males). Carotid plaques were identified in 40.4%. During follow-up, 45 CVE occurred (18 coronary artery disease, 14 peripheral artery disease, 6 stroke, 3 heart failure, 4 deaths) along with 5 non-cardiovascular deaths. Event-free survival declined progressively with increasing plaque burden (log-rank p < 0.001). In unadjusted analyses, the presence of any plaque was associated with increased risk of CVE (HR 3.14, 95%C I 1.69-5.84) and of the composite endpoint (HR 3.07, 95% CI 1.71-5.51). After multivariable adjustment for demographic, metabolic, and microvascular factors, a high plaque burden (≥ 3 plaques) remained associated with CVE (HR 3.38, 95% CI 1.37-8.38) and with the composite endpoint (HR 2.64, 95% CI 1.13-6.21).Conclusions Preclinical carotid atherosclerosis in adults with T1D was independently associated with an increased risk of cardiovascular events and mortality. These findings support the potential role of carotid ultrasound as a complementary tool for cardiovascular risk assessment in individuals with T1D.
SN - 1475-2840
ER -